Medifast MED Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Medifast in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medifast's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Medifast's stock-based comp?
- Medifast (MED) reported stock-based comp of $1.9M in Q1 2026.
- How has Medifast's stock-based comp changed year-over-year?
- Medifast's stock-based comp decreased by 1.8% year-over-year, from $1.93M to $1.9M.
- What is the long-term trend for Medifast's stock-based comp?
- Over 4 years (2021 to 2025), Medifast's stock-based comp has grown at a -6.2% compound annual growth rate (CAGR), from $9.86M to $7.64M.